GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB BioStep Co Ltd (XKRX:278650) » Definitions » Ending Cash Position

HLB BioStep Co (XKRX:278650) Ending Cash Position : ₩45,265 Mil (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is HLB BioStep Co Ending Cash Position?

HLB BioStep Co's Ending Cash Position for the quarter that ended in Sep. 2024 was ₩45,265 Mil.

HLB BioStep Co's quarterly Ending Cash Position declined from Mar. 2024 (₩49,582 Mil) to Jun. 2024 (₩37,267 Mil) but then increased from Jun. 2024 (₩37,267 Mil) to Sep. 2024 (₩45,265 Mil).

HLB BioStep Co's annual Ending Cash Position increased from Dec. 2021 (₩6,158 Mil) to Dec. 2022 (₩14,873 Mil) and increased from Dec. 2022 (₩14,873 Mil) to Dec. 2023 (₩68,799 Mil).

HLB BioStep Co Ending Cash Position Historical Data

The historical data trend for HLB BioStep Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB BioStep Co Ending Cash Position Chart

HLB BioStep Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 5,202.32 8,039.57 6,157.60 14,873.11 68,799.22

HLB BioStep Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,067.91 68,799.22 49,581.63 37,266.51 45,264.77

HLB BioStep Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

HLB BioStep Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=14873.108+53926.11
=68,799

HLB BioStep Co's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=37284.004+7980.766
=45,265

HLB BioStep Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of HLB BioStep Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB BioStep Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB BioStep Co Ltd (XKRX:278650) » Definitions » Ending Cash Position
Comparable Companies
XKRX:138610 XKRX:086820 XKRX:234690 XKRX:011000 XKRX:086890 XKRX:065660 XKRX:288330 XKRX:394800 XKRX:456070 XKRX:083790 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
38, Academy-ro 79beon-gil, Yeonsu-gu, Incheon, KOR, 22014
Website
http://www.knotus.co.kr
HLB BioStep Co Ltd provides non-clinical services necessary for leading domestic and foreign pharmaceutical companies and bio ventures in the process of developing drugs and health functional foods.

HLB BioStep Co Headlines

No Headlines